R Street Institute
Testimony

Jonathan Bydlak testimony for hearing on “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare

by Jonathan Bydlak
March 16, 2022
Print
issues: Budget and Spending Reform, Federal Government Affairs, Governance

Dear Chairman Wyden, Ranking Member Crapo, and Honorable Members of the Committee:

Thank you for the opportunity to submit testimony regarding today’s hearing on “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” This issue is one of vital importance to millions of Americans, and I applaud the Committee’s willingness to address it at such a crucial time.

A recent editorial I authored discusses the topic in detail. I include it below for your consideration. [1]

Thank you again for your leadership on this matter. R Street is happy to advise the Committee in its work or otherwise in any manner that would be helpful.

Respectfully,

Jonathan Bydlak
Director of Governance, R Street Institute
Director of the Fiscal and Budget Policy Project, R Street Institute

[1]  Jonathan Bydlak, “‘Build Back Better’ could limit access to prescription drugs,” The Spectator World, Dec. 6, 2021 https://spectatorworld.com/topic/build-back-better-biden-limit-prescription-drugs.

Featured Publications